Oncogenic BRAF controls many aspects of melanoma cell biology and the common presence of BRAF mutations in nevi, primary, and metastatic melanoma suggests that this phenomenon is an early event in melanomagenesis [37], although the role of BRAF as a prognostic marker is under debate [38,39]. The gene discussed is BRAF; the disease is metastatic melanoma.